{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:34:41Z","timestamp":1769520881219,"version":"3.49.0"},"reference-count":32,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.3892\/ijo.2015.2924","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T09:34:23Z","timestamp":1426152863000},"page":"1994-2002","source":"Crossref","is-referenced-by-count":17,"title":["Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells"],"prefix":"10.3892","volume":"46","author":[{"given":"KOJI","family":"YAMANEGI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MUTSUKI KAWA","family":"BE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROYUKI","family":"FUTANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROSHI","family":"NISHIURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NAOKO","family":"YAMADA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NAHOKO","family":"KATO-KOGOE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROMITSU","family":"KISHIMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHINICHI","family":"YOSHIYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEIJI","family":"NAKASHO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,3,12]]},"reference":[{"key":"key20180107183923_b1-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"515","DOI":"10.5435\/00124635-200908000-00005","article-title":"Osteosarcoma","volume":"17","author":"Messerschmitt","year":"2009","journal-title":"J Am Acad Orthop Surg"},{"key":"key20180107183923_b2-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2013.03.008","article-title":"Interplay between the cancer genome and epigenome","volume":"153","author":"Shen","year":"2013","journal-title":"Cell"},{"key":"key20180107183923_b3-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2009.10.011","article-title":"Epigenetics and cancer treatment","volume":"625","author":"Kristensen","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"key20180107183923_b4-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/156800911794328510","article-title":"Epigenetic regulation of gene expression as an anticancer drug target","volume":"11","author":"Ferguson","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180107183923_b5-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 7","key":"key20180107183923_b6-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1111\/j.1528-1167.2012.03712.x","article-title":"Why are antiepileptic drugs used for nonepileptic conditions?","volume":"53","author":"Bialer","year":"2012","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"key20180107183923_b7-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s10637-010-9596-y","article-title":"Histone deacetylase inhibitors: Potential targets responsible for their anticancer effect","volume":"28","author":"Dickinson","year":"2010","journal-title":"Invest New Drugs"},{"key":"key20180107183923_b8-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-1119(97)00509-X","article-title":"Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells","volume":"204","author":"Tan","year":"1997","journal-title":"Gene"},{"key":"key20180107183923_b9-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1096\/fasebj.13.1.181","article-title":"VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo","volume":"13","author":"Zhai","year":"1999","journal-title":"FASEB J"},{"key":"key20180107183923_b10-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10456-006-9033-1","article-title":"Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients","volume":"9","author":"Parr","year":"2006","journal-title":"Angiogenesis"},{"key":"key20180107183923_b11-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1096\/fj.01-0757fje","article-title":"A novel secreted splice variant of vascular endothelial cell growth inhibitor","volume":"16","author":"Chew","year":"2002","journal-title":"FASEB J"},{"key":"key20180107183923_b12-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1074-7613(02)00283-2","article-title":"TL1A is a TNF-like ligand for DR3 and TR6\/DcR3 and functions as a T cell costimulator","volume":"16","author":"Migone","year":"2002","journal-title":"Immunity"},{"key":"key20180107183923_b13-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s10495-009-0351-9","article-title":"Sensitization of endothelial cells to VEGI-induced apoptosis by inhibiting the NF-kappaB pathway","volume":"14","author":"Grimaldo","year":"2009","journal-title":"Apoptosis"},{"key":"key20180107183923_b14-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3892\/etm.2011.206","article-title":"Aberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer","volume":"2","author":"Ge","year":"2011","journal-title":"Exp Ther Med"},{"key":"key20180107183923_b15-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10456-010-9195-8","article-title":"Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors","volume":"14","author":"Liang","year":"2011","journal-title":"Angiogenesis"},{"key":"key20180107183923_b16-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.274.5289.990","article-title":"Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95","volume":"274","author":"Chinnaiyan","year":"1996","journal-title":"Science"},{"key":"key20180107183923_b17-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/0008-5472.CAN-03-0609","article-title":"Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107183923_b18-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1158\/1078-0432.CCR-05-0384","article-title":"VEGI-192, a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growth","volume":"11","author":"Hou","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180107183923_b19-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12307-012-0117-8","article-title":"TNFSF15 modulates neovascularization and inflammation","volume":"5","author":"Zhang","year":"2012","journal-title":"Cancer Microenviron"},{"key":"key20180107183923_b20-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1042\/BJ20041739","article-title":"Characterization of cis-regulatory elements of the vascular endothelial growth inhibitor gene promoter","volume":"388","author":"Xiao","year":"2005","journal-title":"Biochem J"},{"key":"key20180107183923_b21-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jcb.22185","article-title":"Histone deacetylase inhibitors: Potential in cancer therapy","volume":"107","author":"Marks","year":"2009","journal-title":"J Cell Biochem"},{"key":"key20180107183923_b22-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1073\/pnas.97.3.1230","article-title":"Overexpression of M68\/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster","volume":"97","author":"Bai","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107183923_b23-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s101200200011","article-title":"The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas","volume":"5","author":"Takahama","year":"2002","journal-title":"Gastric Cancer"},{"key":"key20180107183923_b24-ijo-46-05-1994","first-page":"109","article-title":"Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro","volume":"9","author":"Ge","year":"2011","journal-title":"J Exp Ther Oncol"},{"key":"key20180107183923_b25-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.3748\/wjg.v20.i15.4440","article-title":"Death decoy receptor overexpression and increased malignancy risk in colorectal cancer","volume":"20","author":"Zong","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20180107183923_b26-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.1158\/0008-5472.CAN-05-4598","article-title":"Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha","volume":"66","author":"Qian","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107183923_b27-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1128\/MCB.26.6.2019-2028.2006","article-title":"Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha","volume":"26","author":"Kong","year":"2006","journal-title":"Mol Cell Biol"},{"key":"key20180107183923_b28-ijo-46-05-1994","first-page":"193","article-title":"Effects of trichostatin A on HIF-1\u03b1 and VEGF expression in human tongue squamous cell carcinoma cells in vitro","volume":"28","author":"Kang","year":"2012","journal-title":"Oncol Rep"},{"key":"key20180107183923_b29-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3892\/ijo.2013.2193","article-title":"Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo","volume":"44","author":"Zhao","year":"2014","journal-title":"Int J Oncol"},{"key":"key20180107183923_b30-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/cr.2009.126","article-title":"VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis","volume":"20","author":"Xiao","year":"2010","journal-title":"Cell Res"},{"key":"key20180107183923_b31-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/gerona\/glq129","article-title":"Two functionally distinct isoforms of TL1A (TNFSF15) generated by differential ectodomain shedding","volume":"65","author":"M\u00fcck","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key20180107183923_b32-ijo-46-05-1994","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3892\/or.2012.1981","article-title":"Downregulation of matrix metalloproteinase-9 mRNA by valproic acid plays a role in inhibiting the shedding of MHC class I-related molecules A and B on the surface of human osteosarcoma cells","volume":"28","author":"Yamanegi","year":"2012","journal-title":"Oncol Rep"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2015.2924\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T22:23:32Z","timestamp":1566426212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2015.2924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,12]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,3,12]]},"published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.3892\/ijo.2015.2924"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2015.2924","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,12]]}}}